Researchers

Longitudinal Sampling & Event-Based Collection

Get an all-inclusive perspective

Disease characteristics evolve, patient populations are heterogeneous, behavior and environment are dynamic. You need a detailed array of information and unique insight to changes over time to answer analytical questions reliably. But access to comprehensive sample types and datasets, plus support with clinically relevant study designs, may feel out of reach.

Our direct relationship with patients gives you the long-term access you need to complete longitudinal studies and procure biospecimens during key disease-associated pain events for a clinically useful view of biology.

Comprehensive Human Biospecimens & Data

Our longitudinal sampling capabilities are minimally invasive and can be supplemented with real-time data collection via customized methodologies that capture multidimensional concepts such as quality of life, health history, lifestyle factors, demographics, and socioeconomic measures.

Non-Blood-Derived Biofluids

Integumentary Tissues

Real-Time Data Collection

Why Sanguine

Snapshot biospecimens from single moments in time are not enough to effectively translate research findings. Our conceptual framework with longitudinal sampling is all-inclusive and helps prevent expensive stumbles on the clinical stage.

1

Access to more than 50,000 patients nationwide

3

Medical record-verified eligibility

4

More than 90% study retention rate

5

Panoramic, long-term view of study participants

6

Salient, time-dependent insights reduce individual variability and increase statistical power

We Specialize in These Conditions

Behind our therapeutic experience are patient member communities made up of more than 50,000 total members ready to advance science and medicine for the conditions they live with.

icons-70-x-70-genetic

Genetic

icons-70-x-70-neurodegenerative

Neurodegenerative & Neuropsychological

icons-70-x-70-hematological

Hematologic

icons-70-x-70-oncology

Oncology

icons-70-x-70-metabolic

Metabolic

icons-70-x-70-infectious-disease

Infectious Disease

icons-70-x-70-auto-immune-inflammatory

Autoimmune & Inflammatory

cardiovascular

Cardiovascular

icons-70-x-70-genetic

Genetic

icons-70-x-70-neurodegenerative

Neurodegenerative & Neuropsychological

icons-70-x-70-hematological

Hematologic

icons-70-x-70-oncology

Oncology

icons-70-x-70-metabolic

Metabolic

icons-70-x-70-infectious-disease

Infectious Disease

icons-70-x-70-auto-immune-inflammatory

Autoimmune & Inflammatory

cardiovascular

Cardiovascular

Get Samples for My Research

Compliance & Quality Assured

Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.

Sanguine utilizes two commercial, internationally-recognized IRBs for review and approval of all study protocols, specific study documentation, and study participant facing information. 

Advarra is organized and operates in compliance with the US and international regulations and policies governing research with human subjects, as applicable. These include but are not limited to: US federal regulations at 21 CFR parts 50, 56, 312, and 812; US federal regulations at 45 CFR part 46; Part C, Division 5 of the Canadian Food and Drug Regulations; the Canadian Tri-Council Policy Statement 2; and the International Conference on Harmonisation (ICH) E6, Good Clinical Practice (GCP). Advarra may rely upon federal or international guidance to inform its policy development and approaches. Advarra’s IRB is registered with FDA and OHRP. Advarra’s Federalwide Assurance (FWA) has been approved by OHRP; IRB Organization (IORG) Number is 0000635, FWA Number is 00023875 and IRB Registration Number is 00000971. Please note that the IRB registration number applies for both FDA and OHRP registrations and covers all general, therapeutically focused, and country-specific panels. Advarra is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

WCG IRB is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process; all in compliance with requirements of FDA regulations 21 CFR Parts 50 and 56, HHS regulations 45 CFR 46, and International Conference on Harmonization (ICH) E6, Good Clinical Practice (GCP), as applicable. WCG IRB is registered with OHRP/FDA; IRB registration number is IRB00000533, parent organization number is IORG0000432 (WCG IRB Canada registration number is IRB00002354). WCG IRB also reviews in compliance with other applicable federal and state laws and regulations governing IRBs and research with human beings. Where appropriate, WCG IRB complies with additional regulations and guidelines (such as the Canadian Tri-Council Policy Statement, Ethical Conduct for Research Involving Humans) as required in specific research jurisdictions. WCG IRB continues to be fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Others Services

Patient Biospecimen & Data Collection

Patient Surveys & Questionnaires

Onsite & Same-Day Healthy Control Programs